Flow cytometric analysis of supravesicular structures in doxorubicin-containing pegylated liposomes

Chemistry and Physics of Lipids

Volumn 165, Issue 4, 2012, Pages 482-487

  Milosevits, Gergely ^a   Rozsnyay, Zoltán ^b   Kozma, Gergely T ^a,b   Milosevits, János ^a   Tömöry, Gyöngyvér ^a   Robotka, Hermina ^c   Rosivall, László ^a   Szebeni, János ^a,b,c,d  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SeroScience Ltd   (Hungary)

^c Bay Zoltan Ltd   (Hungary)

^d UNIVERSITY OF MISKOLC   (Hungary)

Author keywords

CARPA; Complement; Drug stability; Hypersensitivity reactions; Immune toxicity; Nanomedicines

Indexed keywords

DOXORUBICIN; LATEX; SOLID LIPID NANOPARTICLE;

CALIBRATION; CONFERENCE PAPER; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE; FLUORESCENCE ACTIVATED CELL SORTING; LIGHT SCATTERING; PRIORITY JOURNAL; QUANTITATIVE ASSAY; TRANSMISSION ELECTRON MICROSCOPY;

ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; DRUG STABILITY; FLOW CYTOMETRY; LIPOSOMES; PARTICLE SIZE; POLYETHYLENE GLYCOLS;

EID: 84860741662     PISSN: 00093084     EISSN: 18732941     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2011.11.012     Document Type: Conference Paper

References (21)

1. A.L. Bailey, and P.R. Cullis Liposome fusion Curr. Top. Membr. 44 1997 359 373
2. A. Braun, L. Kwee, M.A. Labow, and J. Alsenz Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic mice Pharm. Res. 14 1997 1472 1478
3. C. Cametti Polyion-induced aggregation of oppositely charged liposomes and charged colloidal particles: the many facets of complex formation in low-density colloidal systems Chem. Phys. Lipids 155 2008 63 73
4. G. De Libero, and L. Mori Recognition of lipid antigens by T cells Nat. Rev. Immunol. 5 2005 485 496
5. Doxil Package Insert 2010 http://www.Doxil.com
6. R.E. Durand Calibration of flow cytometry detector systems Cytometry 2 1981 192 193
7. V. Guida Thermodynamics and kinetics of vesicles formation processes Adv. Colloid Interface Sci. 161 2010 77 88
8. S. Hermeling, D.J. Crommelin, H. Schellekens, and W. Jiskoot Structure-immunogenicity relationships of therapeutic proteins Pharm. Res. 21 2004 897 903
9. H.M. Jakubowski, M. Penas, and K. Saunders The study of lipid aggregates in aqueous solution: formation and properties of liposomes with an encapsulated metallochromic dye J. Chem. Educ. 71 1994 347
10. Y. Lalatonne, J. Richardi, and M.P. Pileni Van der Waals versus dipolar forces controlling mesoscopic organizations of magnetic nanocrystals Nat. Mater. 3 2004 121 125
11. B. Maggio, and J.A. Lucy Studies on mixed monolayers of phospholipids and fusogenic lipids Biochem. J. 149 1975 597 608
12. R.H. Müller, M. Radtke, and S.A. Wissing Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv. Drug Deliv. Rev. 54 November (1) 2002 S131 S155
13. P.A. Patten, and H. Schellekens The immunogenicity of biopharmaceuticals. Lessons learned and consequences for protein drug development Dev. Biol. (Basel) 112 2003 81 97
14. R. Robert Brasseur, B. de Kruijff, and J.-M. Ruysschaert Mode of organization of lipid aggregates: a conformational analysis Biosci. Rep. 4 1984 259 267
15. M. Rovira-Bru, D.H. Thompson, and I. Szleifer Size and structure of spontaneously forming liposomes in lipid/PEG-lipid mixtures Biophys. J. 83 2002 2419 2439
16. S.C. Semple, T.O. Harasym, K.A. Clow, S.M. Ansell, S.K. Klimuk, and M.J. Hope Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic acid J. Pharm. Exp. Ther. 312 2005 1020 1026
17. J. Szebeni, and Y. Barenholz Complement activation, immunogenicity, and immune suppression as potential side effects of liposomes D. Peer, Handbook of Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity, and Applications 2012 Pan Stanford Publishing Pte. Ltd. 311 335
18. J. Szebeni, P. Bedcs, Z. Rozsnyay, Z. Weiszhár, L. Rosivall, R. Cohen, O. Garbuzenko, G. Báthori, M. Tóth, R. Bünger, and Y. Barenholz Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and Ambisome Nanomed. Nanotechnol. Biol. Med. 8 2012 176 184
19. J. Szebeni, F. Muggia, G. Gabizon, and Y. Barenholz Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention Adv. Drug Deliv. Rev. 63 2011 1020 1030
20. S. Vemuri, and C.T. Rhodes Preparation and characterization of liposomes as therapeutic delivery systems: a review Pharm. Acta Helv. 70 1995 95 111
21. K. Vorauer-Uhl, A. Wagner, N. Borth, and H. Katinger Determination of liposome size distribution by flow cytometry Cytometry 39 2000 166 171